Related Experiment Video
Updated: Jun 20, 2026

Isolation, Characterization, and Therapeutic Application of Extracellular Vesicles from Cultured Human Mesenchymal Stem Cells
Published on: September 23, 2022
hTERT-Immortalized Mesenchymal Stem Cell-Derived Extracellular Vesicles: Large-Scale Manufacturing, Cargo Profiling,
Jessica Hindle1, Anastasia Williams2, Yuriy Kim2
1ATCC, Manassas, VA 20110, USA.
Human telomerase reverse transcriptase (hTERT)-immortalized mesenchymal stem cell extracellular vesicles (EVs) show reparative effects on damaged retinal cells. This study establishes a reproducible manufacturing platform for these therapeutic EVs.
Area of Science:
- Ophthalmology
- Regenerative Medicine
- Biotechnology
Background:
- Rising economic burden of vision loss necessitates novel therapeutic strategies.
- Stem cell extracellular vesicles (EVs) demonstrate reparative and immunomodulatory potential.
- Limited research exists on stem cell EVs for ocular damage and hTERT-immortalized cell sources.
Purpose of the Study:
- To establish proof of concept for large-scale manufacturing of hTERT-immortalized MSC EVs.
- To investigate the reparative properties of these EVs on damaged retinal cells.
- To compare the therapeutic potential of hTERT-immortalized MSC EVs with primary MSC EVs.
Main Methods:
- Utilized a large-scale EV-manufacturing platform for reproducible EV production.
- Characterized and profiled cargo of EVs from hTERT-immortalized MSCs.
- Employed cell-based assays to assess EV effects on healthy and damaged retinal pigment epithelial cells.
Main Results:
- Successfully manufactured EVs from hTERT-immortalized MSCs using a reproducible platform.
- hTERT-immortalized MSC EVs demonstrated reparative effects on damaged retinal cells in vitro.
- EVs from hTERT-immortalized MSCs exhibited similar reparative properties to primary MSC EVs.
Conclusions:
- hTERT-immortalized MSCs offer a consistent and reproducible platform for generating therapeutic EVs.
- hTERT-immortalized MSC EVs hold significant therapeutic potential for treating ocular damage.
- This study provides a foundation for further development of EV-based therapies for vision loss.
More Related Videos
04:54Author Spotlight: Standardizing and Improving the Extraction and Purification of Extracellular Vesicles from Human ADSCs
Published on: May 3, 2024
08:50Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics
Published on: August 16, 2024
Related Concept Videos
Telomeres and Telomerase
The Endoplasmic Reticulum